Skip to main content
IMMUPHARMA PLC logo

IMMUPHARMA PLC — Investor Relations & Filings

Ticker · IMM ISIN · GB0033711010 LEI · 213800VZKGHXC7VUS895 IL Professional, scientific and technical activities
Open in API
Filings indexed 443 across all filing types
Latest filing 2022-08-03 Regulatory Filings
Country GB United Kingdom
Listing IL IMM

About IMMUPHARMA PLC

https://www.immupharma.co.uk/

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number : 8312U' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory market announcement. It does not contain detailed financial statements (like 10-K or IR) or management discussion. Given its nature as a brief, specific regulatory notice disseminated via the RNS system, it fits best under the general 'Regulatory Filings' category, as it is not covered by more specific codes like DIV, DIRS, or ER. The 'Menu vs Meal' rule suggests that short announcements about market events should be classified as regulatory filings rather than a core report type.
2022-08-03 English
Subscription/Placing to raise £1.1m; Broker Option
Regulatory Filings Classification · 1% confidence The document is an official announcement from ImmuPharma PLC, identified by the 'RNS Number' header and the date stamp (03 August 2022). The content details a 'Subscription and Placing to raise c£1.1 million' and a 'Sharing Agreement' with a major shareholder (Lanstead). This clearly relates to fundraising, capital structure changes, and the issuance of new shares. This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it involves share issuance (SHA) and director intentions (DIRS), the primary purpose and headline focus is the capital raise itself. It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Since it is a detailed announcement about raising capital via share issuance, CAP is the most appropriate primary classification.
2022-08-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1926 characters) and contains the header 'RNS Number : 8187T'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This type of brief, time-sensitive operational announcement, especially one explicitly sourced from RNS (the news service of the London Stock Exchange) and concerning trading mechanics rather than financial results or governance, fits best under the general regulatory announcement category. Since there is no specific category for trading halts/extensions, and it is not a report itself, the fallback category 'Regulatory Filings' (RNS) is the most appropriate classification.
2022-07-26 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1909 characters) and contains the header 'RNS Number : 8174T' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form operational announcement related to trading mechanics, not a comprehensive financial report or a standard regulatory filing like 10-K or IR. Since it is a specific, non-standard regulatory announcement provided via the RNS system that doesn't fit into the other defined categories (like DIV, ER, or DIRS), the most appropriate classification is the general regulatory announcement fallback category.
2022-07-26 English
Initiation of Research
Regulatory Filings Classification · 1% confidence The document is an RNS announcement dated July 11, 2022, from ImmuPharma PLC. The core content states that their joint broker, Stanford Capital Partners ("SCP"), has initiated research coverage on the Company. It explicitly mentions that the full text of the report can be accessed via SCP's website and Research Tree. Since this document is an announcement about the publication of a research report rather than the report itself, and it is distributed via the RNS system, it fits the description of a Report Publication Announcement (RPA). The document length (4392 chars) is also consistent with a short announcement rather than a full report. Although it is an RNS filing, RPA is more specific for announcing the release of another document.
2022-07-11 English
Confirmed FDA response date for Type C Meeting
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 6038R' and contains standard regulatory boilerplate language, including a reference to 'This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation... On publication of this announcement via a regulatory information service...'. The content itself is an update regarding a Type C Meeting confirmation with the FDA concerning the drug Lupuzor™. This is a specific operational/regulatory update that does not fit the definitions for 10-K, ER, IR, or IP. Since it is a formal announcement disseminated via RNS (Regulatory News Service) and concerns a specific regulatory/operational milestone, it fits best under the general 'Regulatory Filings' category, which serves as a fallback for specific operational news releases not covered by other codes like DIV, CAP, or MANG. Given the context of an RNS release detailing a specific regulatory step, RNS is the most appropriate classification.
2022-07-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.